Paper
9 December 2021 Optical mammography in the time domain up to 1060 nm: from tests on healthy women to initial data for monitoring neoadjuvant chemotherapy
Author Affiliations +
Abstract
We present in vivo tests on healthy women through our optical mammograph in preparation for a clinical validation on neoadjuvant chemotherapy monitoring, and we report preliminary data on the first patient enrolled in the study.
© (2021) COPYRIGHT Society of Photo-Optical Instrumentation Engineers (SPIE). Downloading of the abstract is permitted for personal use only.
Giulia Maffeis, Edoardo Ferocino, Alberto Dalla Mora, Rinaldo Cubeddu, Antonio Pifferi, Carolina Santangelo, Pietro Panizza, and Paola Taroni "Optical mammography in the time domain up to 1060 nm: from tests on healthy women to initial data for monitoring neoadjuvant chemotherapy", Proc. SPIE 11920, Diffuse Optical Spectroscopy and Imaging VIII, 119200O (9 December 2021); https://doi.org/10.1117/12.2615236
Advertisement
Advertisement
RIGHTS & PERMISSIONS
Get copyright permission  Get copyright permission on Copyright Marketplace
KEYWORDS
Breast

Tumors

Collagen

Therapeutics

In vivo imaging

Mammography

Optical testing

Back to Top